Rural Communities Opioid Response Program (RCORP) Grantee Data
Revision of a currently approved collection
No
Regular
Approved without change
08/24/2023
07/03/2023
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
08/31/2026
36 Months From Approved
04/30/2025
664
0
595
877
0
739
0
0
0
HRSA administers the Rural Communities Opioid Response Program (RCORP), which is authorized by section 711(b)(5) of the Social Security Act (42 U.S.C. 912(b)(5)) and is a multi-initiative program that aims to: (1) support treatment for and prevention of substance use disorder (SUD), including opioid use disorder (OUD); and (2) reduce morbidity and mortality associated with SUD, to include OUD, by improving access to and delivering prevention, treatment, and recovery support services to high-risk rural communities. To support this purpose, RCORP grant initiatives include:
⢠RCORP-Implementation grants to fund established networks and consortia to deliver SUD/OUD prevention, treatment, and recovery activities in high-risk rural communities;
⢠RCORP-Neonatal Abstinence Syndrome grants to reduce the incidence and impact of Neonatal Abstinence Syndrome in rural communities by improving systems of care, family supports, and social determinants of health;
⢠RCORP-Psychostimulant Support grants to strengthen and expand prevention, treatment, and recovery services for individuals in rural areas who misuse psychostimulants; to enhance their ability to access treatment and move toward recovery;
⢠RCORP-Medication Assisted Treatment (MAT) Access grants aim to
establish new access points in rural facilities where none currently exist; and
⢠RCORP-Behavioral Health Care support grants aim to expand access to and quality of behavioral health care services at the individual-, provider-, and community-levels.
HRSA currently collects information about RCORP grants using approved performance measures. HRSA developed separate performance measures for RCORPâs new MAT Access and Behavioral Health Care Support grants and seeks OMB approval for the new collection.
There are no changes to the RCORP - Neonatal Abstinence Syndrome/MAT Expansion or RCORP - Psychostimulant Support measures. The proposed changes are new collections for MAT-Access and Behavioral Health Support.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.